Presenters: PD Dr. Arno Kromminga, SVP & Chief Scientific Officer at BioAgilytix and Dr. Lydia Michaut, Scientific Officer at BioAgilytix
Host: Bioanalysis Zone
This webinar discusses the strategies and challenges of immunogenicity assessment for gene therapy compounds, addressing questions such as: What is particular to the immunogenicity of gene therapies as compared to other biologics drugs? Which immunogenicity assessments are recommended from the scientific point of view? What are the bioanalytical tools available? And what are the technical challenges? Learn more about the topics covered in this blog.
Services
Platforms
